Table 1 Summary of 33 cancer types in TCGA

Adrenocortical carcinoma (ACC)

79

43

16,921

16,146

Bladder urothelial carcinoma (BLCA)

407

229

17,469

16,137

Breast invasive carcinoma (BRCA)

1080

204

17,658

12,023

Cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC)

291

88

17,531

16,171

Cholangiocarcinoma (CHOL)

36

22

17,510

15,992

Colon adenocarcinoma (COAD)

279

105

17,454

16,698

Lymphoid Neoplasm Diffuse Large B-cell Lymphoma (DLBC)

47

16

16,897

16,439

Esophageal carcinoma (ESCA)

184

113

18,118

17,285

Glioblastoma multiforme (GBM)

152

131

17,655

16,469

Head and neck squamous cell carcinoma (HNSC)

519

271

17,699

16,248

Kidney chromophobe (KICH)

65

12

17,175

16,421

Kidney renal clear cell carcinoma (KIRC)

531

223

17,662

16,531

Kidney renal papillary cell carcinoma (KIRP)

287

72

17,357

13,727

Acute myeloid leukemia (LAML)

151

92

16,477

14,445

Brain lower grade glioma (LGG)

511

201

17,801

14,036

Liver hepatocellular carcinoma (LIHC)

366

225

16,931

14,581

Lung adenocarcinoma (LUAD)

502

258

17,764

14,936

Lung squamous cell carcinoma (LUSC)

495

252

17,989

17,170

Mesothelioma (MESO)

85

80

17,562

16,705

Ovarian serous cystadenocarcinoma (OV)

302

231

17,968

16,849

Pancreatic adenocarcinoma (PAAD)

177

122

18,007

12,693

Pheochromocytoma and paraganglioma (PCPG)

179

23

17,373

14,346

Prostate adenocarcinoma (PRAD)

497

97

17,700

17,191

Rectum adenocarcinoma (READ)

94

29

17,575

15,504

Sarcoma (SARC)

259

153

17,375

15,299

Skin cutaneous melanoma (SKCM)

102

44

17,298

15,242

Stomach adenocarcinoma (STAD)

393

195

17,967

17,338

Testicular germ cell tumors (TGCT)

134

36

18,471

13,477

Thyroid carcinoma (THCA)

500

60

17,435

16,059

Thymoma (THYM)

119

24

17,646

17,055

Uterine corpus endometrial carcinoma (UCEC)

174

49

17,640

17,047

Uterine carcinosarcoma (UCS)

56

41

17,986

17,606

Uveal melanoma (UVM)

80

34

16,620

16,088